Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurometrix Inc (NURO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,565
  • Shares Outstanding, K 7,880
  • Annual Sales, $ 16,090 K
  • Annual Income, $ 20 K
  • 60-Month Beta 0.66
  • Price/Sales 0.48
  • Price/Cash Flow 41.00
  • Price/Book 1.24
  • Price/Earnings ttm 14.03
  • Earnings Per Share ttm 0.07
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/25/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.150 on 03/28/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -287.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.95 +1.05%
on 04/18/19
1.16 -17.24%
on 03/28/19
-0.10 (-9.43%)
since 03/18/19
3-Month
0.85 +12.94%
on 01/30/19
1.33 -27.82%
on 01/22/19
-0.29 (-23.20%)
since 01/18/19
52-Week
0.60 +60.00%
on 12/24/18
1.77 -45.76%
on 06/19/18
-0.60 (-38.46%)
since 04/18/18

Most Recent Stories

More News
Analysts Estimate NeuroMetrix (NURO) to Report a Decline in Earnings: What to Look Out for

NeuroMetrix (NURO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NURO : 0.96 (-2.26%)
NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 first quarter financial results before the opening of the market on Thursday, April 25, 2019. The Company will host a conference...

NURO : 0.96 (-2.26%)
Earnings Preview: NeuroMetrix (NURO) Q1 Earnings Expected to Decline

NeuroMetrix (NURO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NURO : 0.96 (-2.26%)
Softbank invests in autonomous delivery startup Nuro

TechCrunch reports that SoftBank, a Japanese multinational holding group, has led a $940 million investment in autonomous delivery startup Nuro.

NURO : 0.96 (-2.26%)
GOOGL : 1,241.47 (+0.11%)
GM : 40.30 (+0.78%)
KR : 25.78 (+0.94%)
NeuroMetrix Reports New Clinical Studies Published on DPNCheck

NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheckclinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring...

NURO : 0.96 (-2.26%)
NeuroMetrix Reports Q4 and Full Year 2018 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2018.

NURO : 0.96 (-2.26%)
NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain

NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of results from a randomized controlled trial of Quell in subjects with chronic low back pain in the journal Pain Practice. The paper is titled...

NURO : 0.96 (-2.26%)
Quell Reports Successful CES 2019

NeuroMetrix (Nasdaq: NURO) today announced a successful CES 2019, the world's largest and most influential technology event, which took place January 8 - 11 in Las Vegas. Highlights of the week-long event...

NURO : 0.96 (-2.26%)
NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ: NURO) will issue its fourth quarter 2018 financial results on Thursday morning January 24, 2019. A conference call will be held shortly afterwards at 8:00 a.m. Eastern. The call...

NURO : 0.96 (-2.26%)
Quell Named CES 2019 Innovation Awards Honoree

NeuroMetrix, Inc. (Nasdaq: NURO) announced that it has been named a CES 2019 Innovation Awards Honoree for Quell 2.0 Wearable Pain Relief Technology(TM) in the Fitness, Sports and Biotech product category....

NURO : 0.96 (-2.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade NURO with:

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Key Turning Points

2nd Resistance Point 1.02
1st Resistance Point 0.99
Last Price 0.96
1st Support Level 0.94
2nd Support Level 0.92

See More

52-Week High 1.77
Fibonacci 61.8% 1.32
Fibonacci 50% 1.18
Fibonacci 38.2% 1.05
Last Price 0.96
52-Week Low 0.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar